Shielding in Cystic Fibrosis, A Physical Health Perspective
After a drop in the initial coronavirus (COVID-19) infection rates reported in Germany, there appears to be marked increase in incidence reporting in many federal states.1 This increase in outbreaks leading up to the winter months poses the question of what preparations can we put in place based on what we have learnt in the event of a second wave of COVID-19.
In this webinar Dr Schwarz provides an overview of the physical and clinical health perspectives of COVID-19 during the first wave of the pandemic, highlights the challenges shielding poses for clinician-patient contact, and discusses the importance to review pre-pandemic practices to ensure cystic fibrosis patients are still seen.
With restrictions to routine visits in most cystic fibrosis centres and outpatient clinics, cystic fibrosis care visits require re-evaluating in this age with innovative ways of delivering outpatient care in a COVID safe environment. This includes prescription reviews, detecting exacerbations from home using digital home pulmonary function tests, and alternatives to outpatient visitations. This is not limited to outpatient care but also inpatient care, mental health, physiotherapy, sport engagement, dietician reviews, documentation of data and engagements with other cystic fibrosis centres also require review.
1. Robert Koch Institute. Coronavirus Disease 2019 Daily Situation Report of the Robert Koch Institute. Available at: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/2020-08-14-en.pdf?__blob=publicationFile [Last accessed December 2021].
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Dr Carsten Schwarz
Adult Pneumonologist, Head of the CF Centre, Lung-transplantation programme and Endoscopy Unit